Temmler Werke GmbH was founded in Detmold in 1917 by Hermann Temmler. The Temmler Group is a German pharmaceutical company, which focuses on the production, sale and contract production of pharmaceutical products.[1] In 2012, the Temmler Group was taken over by the Aenova Group and with its seven production sites is one of the largest European pharmaceutical contract manufacturers.
Temmler Pervitin, tablet container; the methamphetamine brand used by German soldiers during World War II.
The Temmler-Werke was founded in Detmold in 1917 by Hermann Temmler. In 1919, it merged with the Vereinigte Chemische Fabriken GmbH in Detmold to form the Vereinigten Chemischen Fabriken H. Temmler pharmaceutical company. In 1925, its headquarters was re-located to Berlin. Preparations for the treatment and alleviation of respiratory diseases became the hallmark of Temmler Pharma.
Temmler plant in Berlin-Johannisthal, production building (2015)
From 1933, the company, with expanded production facilities, concentrated its business activities exclusively around the Berlin area. In 1938, a Temmler chemist in Berlin synthesised Pervitin (methamphetamine-hydrochloride), the pharmaceutical drug was then manufactured and dispensed over-the-counter to the public as a central nervous system and circulatory systemanaleptic, psychiatric performance enhancing stimulant and to induce or extend wakefulness to treat narcolepsy.[2][3] Pervitin was made available and packaged in thirty tablet oral dosage form, and in six 1ccm glass ampulla form as an intramuscular or intravenous injectable. The company became especially known for the introduction of its methamphetamine-hydrochloride preparation brand Pervitin, which the company produced from 1938 up until 1988.[2][4]
According to a Der Spiegel article in 2005, Nazi Germany believed that Pervitin could also help win World War II, so the German armed forces was supplied with more than 35 million Pervitin tablets, especially during Germany's "Blitzkrieg" invasion of Poland and the Battle of France during 1939/40 where it was introduced to soldiers to attenuate anxiety and increase performance and concentration.[2][5]
In 1945, the facility in East Berlin was occupied and disassembled. The company had to be completely reassembled in Hamburg. The company traded under the name Preuss & Temmler AG. The production facilities in East Berlin were sequestered and partially dismantled in 1945, placed under trusteeship from 1946 and expropriated in 1949.[6]
In 1960, the whole company transferred from Hamburg to Marburg.
The Hessian state government awarded the complex, an area of about 40,000 m² of production and administration facilities, a prize for functional and architectural design.[citation needed]
In 1967, the production and storage facilities were extended.
In 1971, a new laboratory building was erected for the manufacture of pharmaceutical dosage forms and active ingredients for controlled release. It became possible, for example, to produce medicinal products in the form of retard pellets releasing their active ingredients when required and over a longer period of time.
In 1982, these retard preparations marked the beginning of contract manufacturing, initially for foreign firms only.
Commencing 1989, the production also comprised all solid pharmaceutical dosage forms for customers at home and abroad.
In 1990, Temmler Pharma became part of the ASTA Medica group. Besides medicinal products for gastroenterology and migraine/pain, pulmology become the focal point of the preparations programme.
In 1998, Temmler Pharma took over 17 established products, thus extending its product range to include pharmaceutical preparations for the treatment of central nervous system disorders.
Since 1999, Temmler Pharma is once again in private hands.
In 2004, the laboratory building was extended by adding two additional floors to 2,500 m², thus laying the foundation for further growth in the field of pharmaceutical development and contract manufacturing services.
A complex comprising 1,380 m² housing production facilities to meet future GMP and FDA standards was erected in 2005. Solid pharmaceutical dosage forms, such as tablets and capsules, and particularly retard formulations, are manufactured at this site.
2007 The acquisition of three European production sites (Germany, Ireland, Italy) from the Japanese pharmaceutical company Astellas on January 1 led to the formation of the Temmler Group, considerably extending production capacities and technological possibilities.
The Temmler Group acquires two further production sites in Feldkirchen and Bruckmühl.
In 2008, with the acquisition of the SwissCo group, based in Sisseln, Switzerland, the Temmler group further develops its competence in the processing of moisture sensitive active substances. The production of effervescent tablets is the chief work of SwissCo.
Today Temmler is one of the leading contract manufacturers in the pharmaceutical industry.[citation needed]
In 2012, Temmler's production facility acquired by Aenova and Temmler's neurology products with the commercial infrastructure and pipeline acquired by major pharma Lupin Limited.
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.
Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin, which operated as an independent company from 1851 to 2006. In 2006, it was bought by Bayer AG and merged to form the Bayer subsidiary Bayer Schering Pharma AG, which was renamed Bayer HealthCare Pharmaceuticals in 2011. Schering was listed on the Frankfurt Stock Exchange and had 26,000 employees as of 2004.
In the manufacture of pharmaceuticals, encapsulation refers to a range of dosage forms—techniques used to enclose medicines—in a relatively stable shell known as a capsule, allowing them to, for example, be taken orally or be used as suppositories. The two main types of capsules are:
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. On February 5, 2020, the company announced management changes effective from April 1, 2020.
Actavis Generics is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial presence across approximately 100 countries. The company has global headquarters in Dublin, Ireland and administrative headquarters in Parsippany-Troy Hills, New Jersey, United States.
Torrent Pharmaceuticals Ltd is an Indian multinational pharmaceutical company, owned by the Rs 37,000 crore Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken. Common among all age groups, dysphagia is observed in about 35% of the general population, as well as up to 60% of the elderly institutionalized population and 18-22% of all patients in long-term care facilities ODTs may have a faster onset of effect than tablets or capsules, and have the convenience of a tablet that can be taken without water. During the last decade, ODTs have become available in a variety of therapeutic markets, both OTC and by prescription.
Patheon is a service brand within Thermo Fisher Scientific’s brand portfolio. Contract development and manufacturing organization (CDMO) services offered under the Patheon brand include small molecule API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials solutions, logistics and commercial manufacturing and packaging. In 2017, Patheon was acquired by Thermo Fisher Scientific to form its Pharma Services business.
A contract manufacturing organization (CMO), more recently referred to as a contract development and manufacturing organization (CDMO) to avoid the acronym confusion of Chief Medical Officer or Clinical Monitoring Organization in the pharma industry, is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.
The Glatt group is active internationally as an equipment manufacturer, system supplier and engineering service provider in the field of processing and refinement of solid compounds for the food / feed, pharmaceutical and fine chemical industry.
Klöckner Pentaplast, also known as “kp” is a manufacturer of plastic packaging products. Headquartered in Luxembourg, with other corporate offices in London UK, Montabaur Germany, and Gordonsville Virginia, USA, kp has a total of 31 facilities in 18 countries, with ca. 5,700 employees worldwide.
JSC Grindex, or simply Grindeks, is an internationally operating Latvian pharmaceutical company with headquarters in Riga, Latvia. Its portfolio consists of original products, generics, and active pharmaceutical ingredients. It mostly focuses on cardiovascular, central nervous system, anti-cancer, and diabetes medicines. Grindex is the leading pharmaceutical manufacturer in the Baltic States. In 2021 Grindex imported products to more than 90 countries.
Akira Ogata was a Japanese chemist and the first to synthesize methamphetamine in crystalline form in 1919.
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company is a major producer of HIV antivirals, as well as gynaecology and blood therapeutic drugs.
The pharmaceutical industry in Pakistan is strictly regulated by the Drug Regulatory Authority of Pakistan, which oversees drug approvals and pricing.
Knoll Pharmaceuticals was a drug development company founded by Albert Knoll and Hans Knoll in Germany in 1886. The company was taken over by German BASF in 1975, which sold it to Abbott Laboratories on 30 June 2002 for $6.9 billion.
The Verband Forschender Arzneimittelhersteller (vfa) or Association of Research-Based Pharmaceutical Companies, is the trade group of 43 pharmaceutical companies in Germany which are global players, representing more than two-thirds of the German pharmaceutical market, with nearly 80,000 employees in Germany.
Wörwag Pharma is a medium-sized family-owned pharmaceutical company headquartered in Böblingen, Germany with subsidiaries in Asia, Europe and South America. It was founded in 1971 by pharmacist Fritz Wörwag in Stuttgart. It sells prescription and over-the-counter preparations and food supplements.
Ahmed Hegazy was an Egyptian-German pharmacist. He conducted research in the Pharmaceutical Technology Department of Bayer from 1966 to 1999, during which time he invented a new galenic formulation for the active components nifedipine and nimodipine. By blocking calcium channels, the substance has a relaxing effect on vascular muscles and is therefore used for the treatment of hypertension. In 1991, Hegazy received the Otto Bayer Medal for the solubilization of poorly soluble ingredients such as nimodipine. His galenic invention is still the basis for many modern formulations at Bayer AG.
Olympia-Werke AG was an important German manufacturer of typewriters. Since the plant in Roffhausen near Wilhelmshaven was closed in 1991, only the brand name has survived.
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.
